<?xml version="1.0" encoding="UTF-8"?>
<modsCollection xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.loc.gov/mods/v3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd">
<mods ID="bio-201503-0003">
	<titleInfo><title>Fetuin-A (AHSG) and its usefulness in clinical practice. Review of the literature</title></titleInfo>
	<name type="personal">
		<namePart type="family">Dabrowska</namePart>
		<namePart type="given">Anna Maria</namePart>
		<role><roleTerm type="text">author</roleTerm></role>
	</name>
	<name type="personal">
		<namePart type="family">Tarach</namePart>
		<namePart type="given">Jerzy Stanislaw</namePart>
		<role><roleTerm type="text">author</roleTerm></role>
	</name>
	<name type="personal">
		<namePart type="family">Wojtysiak-Duma</namePart>
		<namePart type="given">Beata</namePart>
		<role><roleTerm type="text">author</roleTerm></role>
	</name>
	<name type="personal">
		<namePart type="family">Duma</namePart>
		<namePart type="given">Dariusz</namePart>
		<role><roleTerm type="text">author</roleTerm></role>
	</name>
	<typeOfResource>text</typeOfResource>
	<genre>journal article</genre>
	<originInfo><dateIssued>2015</dateIssued></originInfo>
	<language></language>
	<abstract lang="English">Background: Fetuin-A, also called Alpha 2-Heremans Schmid Glycoprotein, is a multifunctional plasma agent what has been proven in animal and human studies. It plays a role as a physiological inhibitor of insulin receptor tyrosine kinase associated with insulin resistance and a negative acute phase reactant. It also regulates bone remodeling and calcium metabolism being an important inhibitor of calcium salt precipitation and vascular calcifications.
Methods: PubMed database was searched for articles from 2002 up to December 2014 to identify the role of fetuin-A in the pathogenesis of selected internal diseases.
Results: Due to secretion of fetuin-A mainly by the liver, it may be a marker of liver function and predictor of mortality in patients with cirrhosis and hepatocellular cancer. The associations between high fetuin-A and metabolic syndrome as well as its hepatic manifestation- nonalcoholic fatty liver disease and atherogenic lipid profile have been well proven. However, fetuin-A relation with BMI is not so clear. Contrary to few reports, many authors suggest that fetuin-A may be an independent risk factor for type 2 diabetes and marker of diabetic complications. Close associations of high and low fetuin-A concentrations with cardiovascular diseases and mortality risk have been reported which is explained by differences in analyzed populations, stages of atherosclerosis and calcifications, coexistence of type 2 diabetes or kidney dysfunction and different main pathways of fetuin-A actions in various diseases.
Conclusions: Fetuin-A has a diagnostic potential as a biomarker for liver dysfunction, cardiovascular diseases and disorders associated with metabolic syndrome.</abstract>
	<subject><topic>fetuin-A</topic></subject>
	<subject><topic>diabetes</topic></subject>
	<subject><topic>obesity</topic></subject>
	<subject><topic>cardiovascular disease</topic></subject>
	<subject><topic>atherosclerosis</topic></subject>
	<identifier type="doi">10.5507/bp.2015.018</identifier>
	<identifier type="uri">https://biomed.papers.upol.cz/artkey/bio-201503-0003.php</identifier>
	<location><url>https://biomed.papers.upol.cz/artkey/bio-201503-0003.php</url></location>
	<relatedItem type="host">
		<titleInfo><title>Biomedical papers</title></titleInfo>
		<originInfo><issuance>continuing</issuance></originInfo>
		<part>
			<detail type="volume"><number>159</number></detail>
			<detail type="issue"><number>3</number></detail>
			<extent unit="pages">
				<start>352</start>
				<end>359</end>
			</extent>
			<date>2015</date>
		</part>
		<identifier type="issn">12138118</identifier>
		<genre authority="marc">periodical</genre>
		<genre>academic journal</genre>
	</relatedItem>
</mods>
</modsCollection>
